Titre : Troubles de stress post-traumatique

Troubles de stress post-traumatique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multimorbidity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Troubles de stress post-traumatique : Questions médicales les plus fréquentes", "headline": "Troubles de stress post-traumatique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Troubles de stress post-traumatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-11", "dateModified": "2025-04-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Troubles de stress post-traumatique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles de stress traumatique", "url": "https://questionsmedicales.fr/mesh/D040921", "about": { "@type": "MedicalCondition", "name": "Troubles de stress traumatique", "code": { "@type": "MedicalCode", "code": "D040921", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.950.750" } } }, "about": { "@type": "MedicalCondition", "name": "Troubles de stress post-traumatique", "alternateName": "Stress Disorders, Post-Traumatic", "code": { "@type": "MedicalCode", "code": "D013313", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "John H Krystal", "url": "https://questionsmedicales.fr/author/John%20H%20Krystal", "affiliation": { "@type": "Organization", "name": "Clinical Neurosciences Division, United States Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, West Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, 300 George Street #901, New Haven, CT 06511, USA. Electronic address: john.krystal@yale.edu." } }, { "@type": "Person", "name": "Claudia Carmassi", "url": "https://questionsmedicales.fr/author/Claudia%20Carmassi", "affiliation": { "@type": "Organization", "name": "Psychiatric Clinic, Department of Clinical and Experimental Medicine, University of Pisa, Italy." } }, { "@type": "Person", "name": "Liliana Dell'Osso", "url": "https://questionsmedicales.fr/author/Liliana%20Dell%27Osso", "affiliation": { "@type": "Organization", "name": "Psychiatric Clinic, Department of Clinical and Experimental Medicine, University of Pisa, Italy." } }, { "@type": "Person", "name": "Jonathan I Bisson", "url": "https://questionsmedicales.fr/author/Jonathan%20I%20Bisson", "affiliation": { "@type": "Organization", "name": "Division of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, United Kingdom. Electronic address: bissonji@cardiff.ac.uk." } }, { "@type": "Person", "name": "Ilan Harpaz-Rotem", "url": "https://questionsmedicales.fr/author/Ilan%20Harpaz-Rotem", "affiliation": { "@type": "Organization", "name": "Clinical Neurosciences Division, United States Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, West Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, 300 George Street #901, New Haven, CT 06511, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Associations of individual chronic diseases and multimorbidity with multidimensional frailty.", "datePublished": "2023-11-04", "url": "https://questionsmedicales.fr/article/37952423", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.archger.2023.105259" } }, { "@type": "ScholarlyArticle", "name": "Healthcare for Older Adults with Multimorbidity: A Scoping Review of Reviews.", "datePublished": "2023-10-16", "url": "https://questionsmedicales.fr/article/37868094", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/CIA.S425576" } }, { "@type": "ScholarlyArticle", "name": "Challenges of caring for older patients with multimorbidity including cancer.", "datePublished": "2023-07-14", "url": "https://questionsmedicales.fr/article/37454533", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jgo.2023.101588" } }, { "@type": "ScholarlyArticle", "name": "Association between multimorbidity with cognitive dysfunction in a Peruvian population.", "datePublished": "2023-01-04", "url": "https://questionsmedicales.fr/article/36634580", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jns.2023.120543" } }, { "@type": "ScholarlyArticle", "name": "A new era of HIV care for age-associated multimorbidity.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36484174", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/QCO.0000000000000890" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Troubles mentaux", "item": "https://questionsmedicales.fr/mesh/D001523" }, { "@type": "ListItem", "position": 3, "name": "Troubles liés aux traumatismes et au stress", "item": "https://questionsmedicales.fr/mesh/D000068099" }, { "@type": "ListItem", "position": 4, "name": "Troubles de stress traumatique", "item": "https://questionsmedicales.fr/mesh/D040921" }, { "@type": "ListItem", "position": 5, "name": "Troubles de stress post-traumatique", "item": "https://questionsmedicales.fr/mesh/D013313" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Troubles de stress post-traumatique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Troubles de stress post-traumatique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Troubles de stress post-traumatique", "description": "Comment diagnostique-t-on le TSPT ?\nQuels critères sont utilisés pour le TSPT ?\nQui peut diagnostiquer le TSPT ?\nLe TSPT peut-il être confondu avec d'autres troubles ?\nQuels tests sont utilisés pour le TSPT ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Troubles de stress post-traumatique", "description": "Quels sont les symptômes principaux du TSPT ?\nLe TSPT cause-t-il des problèmes de sommeil ?\nY a-t-il des symptômes émotionnels associés ?\nLe TSPT entraîne-t-il des problèmes de concentration ?\nLes symptômes du TSPT sont-ils constants ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Troubles de stress post-traumatique", "description": "Peut-on prévenir le TSPT après un traumatisme ?\nQuels facteurs de protection existent contre le TSPT ?\nLes programmes de sensibilisation aident-ils ?\nLe soutien familial est-il important ?\nLes techniques de gestion du stress aident-elles ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Troubles de stress post-traumatique", "description": "Quels traitements sont efficaces pour le TSPT ?\nLes médicaments sont-ils utilisés pour le TSPT ?\nLa thérapie de groupe est-elle bénéfique ?\nLe TSPT peut-il être traité par des approches alternatives ?\nCombien de temps dure le traitement du TSPT ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Troubles de stress post-traumatique", "description": "Quelles complications peuvent survenir avec le TSPT ?\nLe TSPT augmente-t-il le risque de suicide ?\nLe TSPT peut-il affecter la santé physique ?\nLes troubles de l'usage de substances sont-ils fréquents ?\nLe TSPT peut-il affecter la vie professionnelle ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Troubles de stress post-traumatique", "description": "Quels sont les facteurs de risque du TSPT ?\nLe sexe influence-t-il le risque de TSPT ?\nL'âge joue-t-il un rôle dans le TSPT ?\nUn antécédent de troubles mentaux augmente-t-il le risque ?\nLes événements traumatiques répétés augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D013313?mesh_terms=Multimorbidity&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on le TSPT ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation des symptômes et l'historique du patient." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le TSPT ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent l'exposition à un traumatisme et des symptômes persistants." } }, { "@type": "Question", "name": "Qui peut diagnostiquer le TSPT ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un professionnel de santé mentale, comme un psychiatre ou un psychologue, peut diagnostiquer." } }, { "@type": "Question", "name": "Le TSPT peut-il être confondu avec d'autres troubles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec l'anxiété ou la dépression, nécessitant une évaluation approfondie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le TSPT ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de tests spécifiques, mais des questionnaires d'évaluation peuvent être utilisés." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux du TSPT ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des flashbacks, des cauchemars, et une hypervigilance." } }, { "@type": "Question", "name": "Le TSPT cause-t-il des problèmes de sommeil ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de TSPT peuvent souffrir d'insomnie ou de cauchemars fréquents." } }, { "@type": "Question", "name": "Y a-t-il des symptômes émotionnels associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des sentiments de colère, de tristesse ou de détachement émotionnel peuvent survenir." } }, { "@type": "Question", "name": "Le TSPT entraîne-t-il des problèmes de concentration ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes peuvent éprouver des difficultés de concentration et de mémoire." } }, { "@type": "Question", "name": "Les symptômes du TSPT sont-ils constants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils peuvent fluctuer en intensité et être déclenchés par des rappels du traumatisme." } }, { "@type": "Question", "name": "Peut-on prévenir le TSPT après un traumatisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des interventions précoces, comme le soutien psychologique, peuvent réduire le risque de TSPT." } }, { "@type": "Question", "name": "Quels facteurs de protection existent contre le TSPT ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un bon réseau de soutien social et des stratégies de coping efficaces peuvent aider." } }, { "@type": "Question", "name": "Les programmes de sensibilisation aident-ils ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les programmes de sensibilisation peuvent informer sur le TSPT et ses traitements." } }, { "@type": "Question", "name": "Le soutien familial est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien familial peut jouer un rôle crucial dans la prévention et la récupération." } }, { "@type": "Question", "name": "Les techniques de gestion du stress aident-elles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme la méditation et le yoga peuvent réduire le stress post-traumatique." } }, { "@type": "Question", "name": "Quels traitements sont efficaces pour le TSPT ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie cognitivo-comportementale et les médicaments." } }, { "@type": "Question", "name": "Les médicaments sont-ils utilisés pour le TSPT ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antidépresseurs et anxiolytiques peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "La thérapie de groupe est-elle bénéfique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie de groupe peut offrir un soutien et des stratégies de coping aux patients." } }, { "@type": "Question", "name": "Le TSPT peut-il être traité par des approches alternatives ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines approches comme la méditation et l'art-thérapie peuvent aider à gérer les symptômes." } }, { "@type": "Question", "name": "Combien de temps dure le traitement du TSPT ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie, mais peut durer plusieurs mois à plusieurs années selon les cas." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le TSPT ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent la dépression, l'anxiété, et des problèmes relationnels." } }, { "@type": "Question", "name": "Le TSPT augmente-t-il le risque de suicide ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de TSPT ont un risque accru de pensées suicidaires et de tentatives." } }, { "@type": "Question", "name": "Le TSPT peut-il affecter la santé physique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le TSPT peut entraîner des problèmes de santé physique comme des douleurs chroniques." } }, { "@type": "Question", "name": "Les troubles de l'usage de substances sont-ils fréquents ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses personnes atteintes de TSPT développent des troubles liés à l'usage de substances." } }, { "@type": "Question", "name": "Le TSPT peut-il affecter la vie professionnelle ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent interférer avec la concentration et la performance au travail." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du TSPT ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition à des événements traumatiques, l'historique familial et le stress." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de TSPT ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus susceptibles de développer un TSPT après un traumatisme que les hommes." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le TSPT ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes adultes et les adolescents sont souvent plus vulnérables au TSPT." } }, { "@type": "Question", "name": "Un antécédent de troubles mentaux augmente-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un antécédent de troubles mentaux peut accroître le risque de développer un TSPT." } }, { "@type": "Question", "name": "Les événements traumatiques répétés augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes exposées à des traumatismes répétés ont un risque plus élevé de TSPT." } } ] } ] }

Sources (1313 au total)

Associations of individual chronic diseases and multimorbidity with multidimensional frailty.

To examine the associations between individual chronic diseases and multidimensional frailty comprising physical, psychological, and social frailty.... Dutch individuals (N = 47,768) age ≥ 65 years completed a general health questionnaire sent by the Public Health Services (response rate of 58.5 %), including data concerning self-reported chronic dis... The six chronic diseases had medium and strong associations with total ((f... Chronic diseases, in particular urinary incontinence and severe back disorder, were associated with frailty. We thus recommend assigning different weights to individual chronic diseases in a measure o...

Healthcare for Older Adults with Multimorbidity: A Scoping Review of Reviews.

To summarize adverse healthcare outcomes experienced by older adults with multimorbidity and barriers perceived by stakeholders regarding the healthcare systems primarily designed to address individua... We applied the methodology framework developed by Arksey and O'Malley to guide the review. The three-step search strategy was used to identify relevant English reviews that focused on adverse healthca... Twenty reviews were included in this study. Therapeutic competitions, high healthcare service utilization, and high healthcare costs were three adverse healthcare outcomes experienced by patients. Bot... This study conducted a comprehensive overview of the current knowledge related to healthcare for older adults with multimorbidity. In the future, it is necessary to develop more coordinated, continuou...

Challenges of caring for older patients with multimorbidity including cancer.

As the population is ageing, the number of older patients with multimorbidity including cancer continues to increase. To improve care for these patients, the European Union-funded project "Streamlined... An expert panel of cancer and geriatrics specialists participated in an online survey to answer what challenges they experience in caring for older patients with multimorbidity including cancer and wh... Healthcare professionals (n = 36) most frequently mentioned the challenge of choosing the best treatment in light of the lack of evidence in this population and how to handle interactions between the ... In conclusion, the management of older patients with multimorbidity including cancer is complex and although progress has been made on improving aspects of their care, challenges remain and patients a...

Association between multimorbidity with cognitive dysfunction in a Peruvian population.

Previous studies have shown that multimorbidity is a risk factor for cognitive dysfunction (CD).Type 2 diabetes mellitus (T2DM) and hypertension (HT) are very common risk factors.The association betwe... To evaluate the association between multimorbidity due to T2DM and HT with CD among adults ≥50 years in Tumbes.... A secondary analysis of a population-based cross-sectional study was conducted. The exposure variable was the presence of both T2DM and HT, split into categories: without HT or T2DM, only T2DM, only H... 688 participants were analyzed. The prevalence of CD was 39.1%. There was a 56.1% of participants without TDM2 nor HT, 8.3% with T2DM, 28.9% with HT and 6.7% with both diseases. A significant associat... There is association between the morbidity of T2DM and HT, and CD among adults ≥50 years of age in Tumbes. Education was an effect modifier of the association between HT and T2DM on the presence of CD...

A new era of HIV care for age-associated multimorbidity.

The management of people with HIV has shifted focus from acute AIDS-defining illness towards improving detection of chronic disease and reducing impact of multimorbidity. In this review, we explore th... Despite 25 years of the antiretroviral treatment (ART) era an increased incidence of noncommunicable disease (NCD) and multimorbidity in PWH persists. As the world moves closer to universal ART covera... A new era of HIV care for an ageing population with multimorbidity brings challenges for health providers who need to develop holistic patient focused services which span a range of coexisting conditi...

Dietary patterns and prevalence of multimorbidity in women in southern Brazil.

This study aimed to investigate the association between dietary patterns and prevalence of multimorbidity in women.... This population-based cross-sectional study was conducted in 2015 and included 1,128 women aged 20 to 69 years living in the urban area of São Leopoldo municipality, southern Brazil. Multimorbidity wa... The results showed differences in the prevalence of adherence to different dietary patterns and multimorbidity across age groups, with a prevalence of multimorbidity and a healthy dietary pattern show... The results revealed that the prevalence of multimorbidity was significantly lower in women with greater adherence to the Brazilian dietary pattern and highlight the importance of dietary intervention...

Advancing multimorbidity management in primary care: a narrative review.

Multimorbidity, defined as the coexistence of two or more chronic conditions in the same individual, is becoming a crucial health issue in primary care. Patients with multimorbidity utilize health car... To explore evidence on how to advance multimorbidity management, with a focus on primary care. Primary care is where a large number of patients with multimorbidity are managed and is considered to be ... A narrative review was conducted using four major electronic databases consisting of PubMed, Cochrane, World Health Organization database, and Google scholar. In the first round of reviews, priority w... The review found that advancing multimorbidity management in primary care requires a health system approach and a patient-centered approach. The health systems approach includes three major areas: (i)...

A need to integrate pharmacological management for multimorbidity into dementia guidelines in Australia.

Pharmacological management is a vital aspect of dementia care. Suboptimal medication prescribing and adverse drug reactions are major causes for ongoing concerns for the quality of care. This review a... Guideline registries and databases (EMBASE and CINAHL) were searched to identify Australian guidelines addressing pharmacological management in dementia care and to uncover barriers and considerations... Seven Australian guidelines were identified. Barriers to effective implementation were identified at individual, provider, and system levels. None of the identified guidelines provided comprehensive g... Although Australian guidelines are available to guide pharmacological management in dementia, several barriers impede their effective implementation. There is an urgent need for updated guidelines tha...